Industry News (RSS)

Regulatory Affairs


Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”) announced today the closing of its previously announced underwritten public offering of 69,000,000 shares of its common stock, at a public offering price of $1.50 per share.
Posted: January 27, 2023, 12:00 am
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech) announced today that CARTITUDE-4, the Phase 3 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma, met its primary endpoint of showing a statistically significant improvement in progression-free survival (PFS) compared to standard therapy at the study’s first pre-specified interim analysis.
Posted: January 27, 2023, 12:00 am
Qlaris Bio, Inc., a biotechnology company targeting high unmet needs in debilitating ophthalmic diseases, announced today that Thurein Htoo, MS, MBA, the company’s co-founder and chief executive officer, will present during the 12th Annual Glaucoma 360 New Horizons Forum on Friday, Feb. 3, 2023, at 8:40 a.m. PT (11:40 a.m. ET) in San Francisco.
Posted: January 27, 2023, 12:00 am
SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in the Kingdom of Saudi Arabia (KSA).
Posted: January 27, 2023, 12:00 am
Celularity announced Thursday it was conducting a strategic review and warned its workforce to brace for potential layoffs.
Posted: January 27, 2023, 12:00 am


Some scientists who attended the public meeting warned that virus-related research could be unintentionally hampered by the recommendations.
Author: Sarah Owermohle
Posted: January 27, 2023, 11:00 pm
After resigning as White House science adviser over bullying allegations, Eric Lander is returning to the Broad Institute and faculty posts at MIT and Harvard.
Author: Megan Molteni
Posted: January 27, 2023, 8:39 pm
A U.K. pharmaceutical industry trade group ruled on a complaint that Pfizer CEO Albert Bourla's remarks to the BBC were “extremely promotional in nature.”
Author: Ed Silverman
Posted: January 27, 2023, 8:23 pm
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
Author: Ed Silverman
Posted: January 27, 2023, 4:29 pm
The proposed change would do away with the current three-month abstinence requirement for donations from men who have sex with men.
Author: Matthew Perrone — Associated Press
Posted: January 27, 2023, 3:19 pm

Human Resources

Benefits teams will need to ensure their packages meet employees’ most pressing needs while justifying their investments to leadership.

Author: Ryan Golden
Posted: January 27, 2023, 9:33 pm

While quiet quitting is nothing new, leaders need to respond in new ways, panelists agreed.

Author: Ginger Christ
Posted: January 27, 2023, 7:56 pm

Amid a tech talent shakeup, Comcast supports L&D initiatives to increase broadband infrastructure in underserved and unserved communities.

Author: Caroline Colvin
Posted: January 27, 2023, 3:19 pm

But DEI initiatives may be among the first cut during times of economic uncertainty, other reports have said.

Author: Laurel Kalser
Posted: January 27, 2023, 3:13 pm

Software and data professions command the highest percentage of flexible work options, a Remote report shows.

Author: Matt Ashare
Posted: January 27, 2023, 3:13 pm